Selective Serotonin Reuptake Inhibitors and Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation: An Analysis From the ROCKET AF Trial

BACKGROUND: There is concern that selective serotonin reuptake inhibitors (SSRIs) substantially increase bleeding risk in patients taking anticoagulants. METHODS AND RESULTS: We studied 737 patients taking SSRIs in the ROCKET AF (Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared With...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Am Heart Assoc
Main Authors: Quinn, Gene R., Hellkamp, Anne S., Hankey, Graeme J., Becker, Richard C., Berkowitz, Scott D., Breithardt, Günter, Fava, Maurizio, Fox, Keith A. A., Halperin, Jonathan L., Mahaffey, Kenneth W., Nessel, Christopher C., Patel, Manesh R., Piccini, Jonathan P., Singer, Daniel E.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2018
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6201450/
https://ncbi.nlm.nih.gov/pubmed/30371223
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.118.008755
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados